Plain-English translation of NCT06168019 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand how COVID-19, influenza, and other respiratory viruses affect pregnant women and their babies. This is an observational study, which means you'll receive your normal pregnancy care while researchers track your health through regular check-ins and blood tests to see if and when you get these infections.
Pregnant women can be more vulnerable to serious illness from respiratory viruses, and these infections may affect the developing baby and newborn. This study aims to understand how common these infections are during pregnancy and what effects they have on mothers and infants, so doctors can better protect pregnant women in the future.
You likely qualify if…
You likely don't qualify if…
You'll receive all your normal prenatal, delivery, and postpartum care at the hospital. The research adds regular check-ins: you'll be called or texted twice weekly to report any symptoms like fever or cough, use a provided thermometer to track your temperature, and keep a symptom diary. You'll have blood drawn at four timepoints—at your first visit, around 28-34 weeks, around 37 weeks, and after delivery. If you get hospitalized with COVID-19, additional blood samples may be collected. The study follows you through 42 days after delivery or after a miscarriage if one occurs.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States
India